Metropolis Healthcare reported a 23% increase in Q4 revenue, primarily due to strong performance by TruHealth and specialized testing. Both B2C and B2B segments showed growth, with B2C up 19% and B2B up 30%. Organic revenue also increased by 14.5%, while EBITDA margins improved as well.